Lei D. Dou

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Treatment Preferences in Adult Patients with Type 2 and Type 3 Spinal Muscular Atrophy: Evidence from a Discrete Choice Experiment in China.

Treatment Preferences in Adult Patients with Type 2 and Type 3 Spinal Muscular Atrophy: Evidence from a Discrete Choice Experiment in China.

Journal: The patient

Published: September 23, 2025

Health-related quality of life and correlation with clinical severity in patients with acne: a cross-sectional study at a single centre in China.

Health-related quality of life and correlation with clinical severity in patients with acne: a cross-sectional study at a single centre in China.

Journal: BMJ open

Published: September 02, 2025

Developing and testing bolt-on enhanced EQ-5D-5L for assessing Chinese patients with chronic obstructive pulmonary disease: a mixed-methods study protocol.

Developing and testing bolt-on enhanced EQ-5D-5L for assessing Chinese patients with chronic obstructive pulmonary disease: a mixed-methods study protocol.

Journal: BMJ open respiratory research

Published: June 24, 2025

Mapping Health State Utility from Disease-Specific Measures in Spinal Muscular Atrophy and Paroxysmal Nocturnal Hemoglobinuria.

Mapping Health State Utility from Disease-Specific Measures in Spinal Muscular Atrophy and Paroxysmal Nocturnal Hemoglobinuria.

Journal: PharmacoEconomics

Published: May 29, 2025

Cost-effectiveness of antibody-drug conjugates in previously treated metastatic triple-negative breast cancer in China.

Cost-effectiveness of antibody-drug conjugates in previously treated metastatic triple-negative breast cancer in China.

Journal: Health economics review

Published: May 23, 2025

Cost-effectiveness analysis of cadonilimab plus bevacizumab and chemotherapy for persistent, recurrent, or metastatic cervical cancer.

Cost-effectiveness analysis of cadonilimab plus bevacizumab and chemotherapy for persistent, recurrent, or metastatic cervical cancer.

Journal: Frontiers in immunology

Published: April 08, 2025

The Humanistic and Economic Burden of COPD Patients in Urban China: A Propensity Score Matching Study.

The Humanistic and Economic Burden of COPD Patients in Urban China: A Propensity Score Matching Study.

Journal: International journal of chronic obstructive pulmonary disease

Published: February 20, 2025

Cost-effectiveness of cadonilimab plus chemotherapy in the first-line treatment of HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma.

Cost-effectiveness of cadonilimab plus chemotherapy in the first-line treatment of HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma.

Journal: Therapeutic advances in gastroenterology

Published: February 17, 2025

Cost-effectiveness of inavolisib-based therapy in PIK3CA-mutated advanced breast cancer in the USA.

Cost-effectiveness of inavolisib-based therapy in PIK3CA-mutated advanced breast cancer in the USA.

Journal: Breast (Edinburgh, Scotland)

Published: December 09, 2024

Cost-effectiveness of sacituzumab govitecan for hormone receptor-positive human epidermal growth factor receptor 2-negative metastatic breast cancer based on the EVER-132-002 trial in China.

Cost-effectiveness of sacituzumab govitecan for hormone receptor-positive human epidermal growth factor receptor 2-negative metastatic breast cancer based on the EVER-132-002 trial in China.

Journal: Cost effectiveness and resource allocation : C/E

Published: November 20, 2024

Comparison of EQ-5D-Y-3L Utility Scores Using Nine Country-Specific Value Sets in Chinese Adolescents.

Comparison of EQ-5D-Y-3L Utility Scores Using Nine Country-Specific Value Sets in Chinese Adolescents.

Journal: PharmacoEconomics

Published: October 23, 2024

Clinical, humanistic, and economic burden of haemophilia A in China: findings from a real-world survey.

Clinical, humanistic, and economic burden of haemophilia A in China: findings from a real-world survey.

Journal: Orphanet journal of rare diseases

Published: September 25, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026